Bayer Aktiengesellschaft: Correction of a release from 08/04/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
April 09, 2020 at 05:40 am EDT
Share
DGAP Voting Rights Announcement: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Correction of a release from 08/04/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
09.04.2020 / 11:37
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
Name:
Bayer Aktiengesellschaft
Street:
Kaiser-Wilhelm-Allee 1
Postal code:
51373
City:
Leverkusen Germany
Legal Entity Identifier (LEI):
549300J4U55H3WP1XT59
2. Reason for notification
X
Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
X
Other reason: Voluntary group notification with triggered threshold on subsidiary level: decrease under 3%
3. Details of person subject to the notification obligation
Legal entity: Amundi S.A. City of registered office, country: Paris, France
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached:
02 Apr 2020
6. Total positions
% of voting rights attached to shares (total of 7.a.)
% of voting rights through instruments (total of 7.b.1 + 7.b.2)
Total of both in % (7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New
3.07 %
0.015 %
3.09 %
982424082
Previous notification
3.22 %
n/a %
3.22 %
/
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN
Absolute
In %
Direct (Sec. 33 WpHG)
Indirect (Sec. 34 WpHG)
Direct (Sec. 33 WpHG)
Indirect (Sec. 34 WpHG)
DE000BAY0017
30148065
%
3.07 %
Total
30148065
3.07 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Voting rights absolute
Voting rights in %
security lending (right to recall)
n/a
n/a
150000
0.015 %
Total
150000
0.015 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Cash or physical settlement
Voting rights absolute
Voting rights in %
%
Total
%
8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name
% of voting rights (if at least 3% or more)
% of voting rights through instruments (if at least 5% or more)
Total of both (if at least 5% or more)
Amundi S.A.
%
%
%
Amundi Asset Management S.A.S.
%
%
%
Amundi S.A.
%
%
%
Societe Generale Gestion
%
%
%
Amundi S.A.
%
%
%
BFT Investment Managers
%
%
%
Amundi S.A.
%
%
%
Amundi Asset Management S.A.S.
%
%
%
Amundi Japan Holding Ltd.
%
%
%
Amundi Japan Ltd.
%
%
%
Amundi S.A.
%
%
%
Amundi Asset Management S.A.S.
%
%
%
Amundi SGR SpA
%
%
%
Amundi S.A.
%
%
%
Etoile Gestion
%
%
%
Amundi S.A.
%
%
%
Amundi Asset Management S.A.S.
%
%
%
Amundi Iberia SGIIC, SA.
%
%
%
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights
Proportion of instruments
Total of both
%
%
%
10. Other explanatory remarks:
Date
07 Apr 2020
09.04.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Bayer Aktiengesellschaft: Correction of a release from 08/04/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
BAYER AG 
